Clinical Practice and Diagnostic Trends in Hereditary Transthyretin Amyloidosis: A 25-Year Observational Study
Medicina · 07.05.2026 · 62 (5) · 907
DOI: 10.3390/medicina62050907 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medicina, online erschienen am 07.05.2026. Verfasst von Kaori Sumi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, Oita University, Oita 879-5593, Japan. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-Aid for Scientific Research (C).
Abstract (Originalsprache)
Background and Objectives: Hereditary transthyretin amyloidosis (ATTRv), a multisystemic disorder caused by transthyretin (TTR) gene mutations, exhibits phenotypic heterogeneity that can hamper recognition in non-endemic areas. Here, we investigated the clinical practice of ATTRv amyloidosis over an extended period and examined the challenges currently faced in non-endemic regions. Materials and Methods: We conducted an observational study of 18 patients with ATTRv amyloidosis diagnosed at Oita University and its affiliated hospitals between 2000 and 2025, using both retrospective and prospective data collection, to evaluate clinical features, treatments, and outcomes.
Results
The median age at disease onset was 64 years, and 27.8% of patients had a family history of the disease. Val30Met (V30M) was the most common (55.6%) mutation; Tyr114Ser was the most common non-V30M variant. Sensory disturbances (50%) were the most common initial symptoms, followed by cardiac symptoms (38.9%). The cardiology department most frequently diagnosed ATTRv amyloidosis, followed by the neurology department. Two patients were relatives of previously diagnosed probands and were therefore identified during their first visit to the initial department. New diagnoses increased over time (1 in 2000–2009, 7 in 2010–2019, and 10 in 2020–2025), although diagnostic delays persisted. After the therapeutic agents shifted from patisiran to vutrisiran, the serum TTR value decreased (p = 0.0078) without significant deterioration in cardiac parameters. In the current treatment era, longer-term survivors have been observed, but multiple organ dysfunction has become more apparent, and ocular manifestations have emerged as a clinically important problem, particularly in patients with longer disease duration (p = 0.0169).
Conclusions
Physicians in various departments must remain vigilant for the presence of ATTRv amyloidosis. Addressing challenges faced by long-term survivors, including ocular manifestations and central nervous system complications, has become crucial, even in non-endemic areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
- Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
- Department of Neurology, Oita Prefectural Hospital, Oita 870-851, Japan.
- Department of Neurology, Shin Beppu Hospital, Oita 874-8538, Japan.
- Department of Clinical Physiology, Graduate School of Life Sciences, Kumamoto University, Kumamoto 862-0976, Japan.
- Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
ORCID-Profile: Kaori Sumi, Teruaki Masuda, Mitsuharu Ueda, Naohiko Takahashi, Noriyuki Kimura
Förderung
- Grants-in-Aid for Scientific Research (C)
Zitieren
APA
Sumi, K., Masuda, T., Kondo, H., Saito, S., Aso, Y., Hazama, Y., Obayashi, K., Nomura, T., Ueda, M., Takahashi, N., & Kimura, N. (2026). Clinical Practice and Diagnostic Trends in Hereditary Transthyretin Amyloidosis: A 25-Year Observational Study. Medicina, 62(5), 907. https://doi.org/10.3390/medicina62050907
Vancouver
Sumi K, Masuda T, Kondo H, Saito S, Aso Y, Hazama Y, et al. Clinical Practice and Diagnostic Trends in Hereditary Transthyretin Amyloidosis: A 25-Year Observational Study. Medicina. 2026;62(5):907. doi:10.3390/medicina62050907
BibTeX
@article{Sumi2026,
author = {Sumi, Kaori and Masuda, Teruaki and Kondo, Hidekazu and Saito, Shotaro and Aso, Yasuhiro and Hazama, Yusuke and Obayashi, Konen and Nomura, Toshiya and Ueda, Mitsuharu and Takahashi, Naohiko and Kimura, Noriyuki},
title = {Clinical Practice and Diagnostic Trends in Hereditary Transthyretin Amyloidosis: A 25-Year Observational Study},
journal = {Medicina},
year = {2026},
volume = {62},
number = {5},
pages = {907},
doi = {10.3390/medicina62050907}
}
EUVIMED